A detailed history of Morgan Dempsey Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Morgan Dempsey Capital Management LLC holds 61 shares of ABT stock, worth $7,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 61 -0.0%
Holding current value
$7,244
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$96.86 - $114.01 $8,523 - $10,032
-88 Reduced 59.06%
61 $6,000
Q3 2022

Oct 18, 2022

BUY
$96.76 - $112.03 $14,417 - $16,692
149 New
149 $14,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Morgan Dempsey Capital Management LLC Portfolio

Follow Morgan Dempsey Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Dempsey Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Dempsey Capital Management LLC with notifications on news.